India Medical Device 2026 concluded with a clear message from policymakers, industry leaders, regulators, investors, and innovators: India's medical devices sector is entering a new phase of growth. The focus is increasingly on strengthening the country's position as a global hub for quality medical devices through manufacturing competitiveness, innovation, investments, regulatory advancement, and export growth. Organized by the Department of Pharmaceuticals in partnership with (FICCI Federation of Indian Chambers of Commerce and Industry), the conference brought together stakeholders from across the MedTech ecosystem to deliberate on policy priorities, regulatory reforms, research and innovation, technology adoption, investment opportunities, and global partnerships. These discussions reflected a shared commitment to advancing India's MedTech sector in line with the broader vision of Viksit Bharat.
Strategic Priorities for the Next Phase of Growth
1. Strengthen Quality and Regulatory Excellence
A consistent theme across discussions was the need to enhance quality systems and regulatory capabilities to support global competitiveness. As Indian manufacturers expand their presence in international markets, alignment with global standards and regulatory excellence will remain critical enablers of growth.
2. Accelerate Innovation and Research
Stakeholders highlighted the importance of continued investment in research, innovation, and technology adoption. Strengthening collaboration among industry, academia, healthcare providers, start-ups, and investors will be essential to translate innovation into scalable healthcare solutions.
3. Expand Evidence Generation and Adoption
The importance of generating robust local clinical evidence emerged as a key consideration for the sector. Strengthening evidence generation can help accelerate adoption, demonstrate value to healthcare providers, support regulatory and market access requirements, and ultimately improve patient outcomes.
4. Foster Ecosystem Collaboration and Global Partnerships
The conference reinforced the importance of collaboration across the MedTech ecosystem. Greater engagement among policymakers, regulators, manufacturers, innovators, investors, and healthcare organizations will be necessary to drive sustainable growth and strengthen India's position in global MedTech value chains.
IQVIA MedTech Perspective
India Medical Device 2026 reflected growing alignment between government, industry, and the broader healthcare ecosystem on the priorities required to advance the sector. While significant progress has been made in strengthening domestic capabilities, the next phase will depend on continued focus on quality, innovation, clinical evidence generation, regulatory advancement, and ecosystem collaboration. The opportunity ahead extends beyond manufacturing growth. By combining strong policy support, research-led innovation, quality excellence, and evidence-based adoption, India can further strengthen its role in the global medical devices landscape while delivering meaningful improvements in healthcare outcomes.
